Skip to main content
Ascletis Pharma Inc. logo

Ascletis Pharma Inc. — Investor Relations & Filings

Ticker · 1672 ISIN · KYG0520K1094 LEI · 254900SKEFCO9I3GPL05 HKEX Manufacturing
Open in API
Filings indexed 1,479 across all filing types
Latest filing 2012-11-01 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 1672

About Ascletis Pharma Inc.

http://www.ascletis.com

Ascletis Pharma Inc. is a fully integrated, R&D driven biotechnology company dedicated to the development and commercialization of potential best-in-class and first-in-class therapeutics. The company covers the entire value chain from discovery to sales. Ascletis primarily focuses on metabolic diseases, including chronic weight management, utilizing proprietary platforms such as Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD), Ultra-Long-Acting Platform (ULAP), and Peptide Oral Transport ENhancement Technology (POTENT). Key pipeline candidates include ASC30 (oral/subcutaneous GLP-1R agonist), ASC35 (GLP-1R/GIPR dual agonist), ASC36 (amylin receptor agonist), and ASC37 (GLP-1R/GIPR/GCGR triple agonist). The company also maintains active programs in viral diseases, NASH/PBC, and oncology.

Recent filings

Filing Released Lang Actions
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 95% confidence The document is an announcement listing the members of the board of directors and their roles and functions, including details about standing committees. It does not contain financial data, audit results, or meeting materials. It is not a report or a voting result announcement. The content clearly relates to board/management information, specifically about the composition and roles of the board. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and focused solely on board composition, supporting this classification with high confidence.
2012-11-01 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR, MEMBER OF AUDIT COMMITTEE, MEMBER OF REMUNERATION COMMITTEE AND MEMBER OF NOMINATION COMMITTEE
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new Independent Non-executive Director and member of various committees of the company. It details the individual's background, terms of appointment, and confirms no conflicts of interest. There is no financial data, report, or regulatory filing referenced beyond the appointment itself. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2012-11-01 English
Lease of a lot in EcoPark
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the lease of a lot in EcoPark by the company World Houseware (Holdings) Limited. It details the lease terms, parties involved, rent, security deposit, guarantee, and other lease conditions. The document is a formal announcement made pursuant to a listing rule (Rule 13.09 of the Listing Rules) and does not contain financial statements, audit information, management discussion, or other report content. It is not a report itself but an announcement of a corporate transaction related to property lease. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a capital/financing update or share issue. The closest fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories. The document length is 9130 characters, which is substantial but the content is clearly an announcement of a lease agreement, not a financial report or detailed presentation. Therefore, the appropriate classification is Regulatory Filings (RNS).
2012-10-12 English
PATENT TECHNOLOGIES ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors of World Houseware (Holdings) Limited regarding the granting of patent certificates for various inventions by the company's subsidiary. It details the patents granted and those pending application. There is no financial data, no mention of financial results, no shareholder voting information, no management changes, no legal proceedings, no capital or financing updates, and no regulatory certifications. The document is an announcement of intellectual property achievements, which does not fit into categories like Annual Report, Interim Report, Earnings Release, or others related to financial or governance disclosures. It is a general regulatory announcement informing the market about patent grants, which fits best under Regulatory Filings (RNS) as a miscellaneous announcement that does not fit other specific categories. The document length is under 5,000 characters and is a standalone announcement, not a report or presentation.
2012-10-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2012
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/9/2012, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital/financing update or a regulatory compliance report. Given the detailed nature of share capital changes and the monthly frequency, this fits best under Capital/Financing Update (CAP). The document length is substantial and contains detailed data, not just an announcement or certification, so it is not RPA or RNS. Therefore, the classification is CAP with high confidence.
2012-10-03 English
INTERIM REPORT 2012
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2012' and contains detailed financial statements such as the Condensed Consolidated Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flows for the six months ended 30 June 2012. It also includes notes to the condensed consolidated financial statements and a report on review of these statements. The presence of unaudited interim financial data and the reference to HKAS 34 'Interim Financial Reporting' confirms this is a comprehensive financial report for a period shorter than a full fiscal year. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement or summary. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2012
2012-09-17 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.